Topic: mosquito-bourne illness
Zika vaccine research continues in the absence of a large-scale outbreak, but a shortage of cases is making it hard to test for efficacy.
NIH has launched a phase 1 trial to test a vaccine that aims to fight a wide range of mosquito-borne diseases.
Plans are being laid for India and the U.S. to work together on the development of vaccines for dengue fever and other diseases that pose a major threat to public health.
This week, Austrian biotech Themis Bioscience said it’s starting a Phase II for its Chikungunya virus vaccine, what it calls “the most advanced” candidate of its kind.